Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan

Brain and Development

Volumn 25, Issue 7, 2003, Pages 514-517

  Tomoda, Akemi ^a   Nomura, Keiko ^a   Shiraishi, Seiji ^a   Hamada, Akinobu ^a   Ohmura, Takafumi ^a   Hosoya, Mitsuaki ^b   Miike, Teruhisa ^a   Sawaishi, Yukio ^c   Kimura, Hiroshi ^d   Takashima, Hiroshi ^e   Tohda, Yoshihiro ^e   Mori, Kenji ^f   Kato, Zenichiro ^g   Fukushima, Ai ^h   Nishio, Hisanori ⁱ   Nezu, Akio ^j   Nihei, Kenji ^k  

^a KUMAMOTO UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c AKITA UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SAGA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

^g GIFU UNIVERSITY   (Japan)

^h National Center Hospital for Mental   (Japan)

ⁱ MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

^j YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^k NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

more..

Author keywords

Interferon (IFN); Ribavirin; Subacute sclerosing panencephalitis (SSPE)

Indexed keywords

BETA INTERFERON; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FATIGUE; FEMALE; GINGIVITIS; HEADACHE; HUMAN; JAPAN; LIP DISEASE; LIP SWELLING; MALE; NAUSEA; PIGMENTATION; SIDE EFFECT; SOMNOLENCE; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 0344873620     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(03)00062-7     Document Type: Article

References (10)

1. Dyken P.R. Viral diseases of the nervous system. Swaiman K.F. Pediatric Neurology-Principles and Practice. 1:1999;499-503 CV Mosby, St. Louis.
2. Anlar B., Yalaz K., Oktem F., Kose G. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular α interferon. Neurology. 48:1997;526-528.
3. Hosoya M., Shigeta S., Nakamura K., De Clercq E. Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. Antiviral Res. 12:1989;87-98.
4. Ishii T., Hosoya M., Mori S., Shigeta S., Suzuki H. Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis. Antimicrob Agents Chemother. 40:1996;241-243.
5. Takahashi T., Hosoya M., Kimura K., Ohno K., Mori S., Takahashi K., et al. The cooperative effect of interferon-α and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo. Antiviral Res. 37:1998;29-35.
6. Stephen B.T., Ramel A.C., Cormac A.O. Intraparenchymal alpha-interferon and intraventricular ribavirin for subacute sclerosing panencephalitis (SSPE). Neurology (suppl.). 54:2000;A430.
7. Jabbour J.T., Duenas D.A., Modlin J. SSPE: clinical staging, course and frequency. Arch Neurol. 32:1975;493-495.
8. Dyken P.R., Swift A., Durant R.H. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol. 11:1982;359-364.
9. Tomoda A., Shiraishi S., Hosoya M., Hamada A., Miike T. Combined treatment with interferon-α and ribavirin for subacute sclerosing panencephalitis. Pediatr Neurol. 24:2001;54-59.
10. Hosoya M., Shigeta S., Mori S., Tomoda A., Shiraishi S., Miike T., et al. High dose intravenous ribavirin therapy for subacute sclerosing panencephalitis (SSPE). Antimicrob Agents Chemother. 45:2001;943-945.